Becker's Healthcare September 13, 2024
Erica Carbajal

Tampa, Fla.-based Moffitt Cancer Center and drugmaker AstraZeneca are collaborating to accelerate the development of CAR-T cell and T cell receptor therapies.

“We are excited to collaborate with AstraZeneca to push the boundaries of what’s possible in cancer treatment,” Patrick Hwu, MD, Moffitt’s president and CEO, said in a Sept. 13 news release. “By combining our clinical expertise with AstraZeneca’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Partnerships, Pharma / Biotech, Provider, Trends
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article